{"id":138695,"date":"2018-09-07T06:20:38","date_gmt":"2018-09-07T11:20:38","guid":{"rendered":"http:\/\/www.ict-pulse.com\/?p=138695"},"modified":"2018-09-07T06:51:08","modified_gmt":"2018-09-07T11:51:08","slug":"3-lessons-learn-spectacular-rise-fall-theranos","status":"publish","type":"post","link":"https:\/\/ict-pulse.com\/2018\/09\/3-lessons-learn-spectacular-rise-fall-theranos\/","title":{"rendered":"3 lessons we can learn from the spectacular rise and fall of Theranos"},"content":{"rendered":"

Theranos was the darling of the tech and healthcare fields in the United States, and at one time was valued at USD\u00a090\u00a0billion. Now, it is worth nothing. Here we share three takeaways we can all learn from the spectacular rise and fall of that firm.<\/em><\/p>\n

If you do have any interest in the global tech space, you should have heard of Elizabeth Holmes. Holmes was the Founder and Chief Executive Officer of Theranos<\/a>, a 15 year old heath tech company that claimed to have developed breakthrough technology that would allow it to conduct a broad range of blood tests using less blood and being considerably more cost effective than the traditional practice.<\/p>\n

Holmes and Theranos became the darlings of the tech and health fields, and secured considerable funding, including most recently over USD\u00a090 million dollars, to continue to build out the company. However, in recent years, there had been rumours that all was not \u2018kosher\u2019 at Theranos:<\/p>\n